Bell Investment Advisors, Inc Immunic, Inc. Transaction History
Bell Investment Advisors, Inc
- $603 Million
- Q3 2025
A detailed history of Bell Investment Advisors, Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 649 shares of IMUX stock, worth $486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
649Holding current value
$486% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
42.5MCall Options Held
128KPut Options Held
90.7K-
Abrdn PLC8.24MShares$6.18 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.74 Million0.35% of portfolio
-
Avidity Partners Management LP Dallas, TX4.7MShares$3.52 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.1MShares$2.33 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $22.9M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...